Tobramycin Solution
Product Images NDC 72603-430

22 FDA label images from Northstar Rxllc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 72603-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (98c53b08 1ee0 42d8 89a7 1443b7a7f440 01)

Structure (98c53b08 1ee0 42d8 89a7 1443b7a7f440 01)
Chemical structure diagram depicting the molecular structure of Tobramycin, the active ingredient in TOBRAMYCIN inhalation solution 300 mg/5mL by NorthStar RxLLC.*
FDA Label Image

Figure 1: Relative Change From Baseline In Fev 1% Predicted (98c53b08 1ee0 42d8 89a7 1443b7a7f440 02)

Figure 1: Relative Change From Baseline In Fev 1% Predicted (98c53b08 1ee0 42d8 89a7 1443b7a7f440 02)
A line graph depicting the average relative change in FEV1 percentage predicted over 24 weeks for Tobramycin Inhalation Solution and placebo in two studies. The x-axis shows time in weeks, and the y-axis shows the change in FEV1. Four lines represent Study 1 and Study 2 for both Tobramycin and placebo groups, with marked periods labeled 'on drug.' The graph illustrates the FEV1 response trends for these groups.*
FDA Label Image

Figure 2: Absolute Change From Baseline In Log 10 Cfus (98c53b08 1ee0 42d8 89a7 1443b7a7f440 03)

Figure 2: Absolute Change From Baseline In Log 10 Cfus (98c53b08 1ee0 42d8 89a7 1443b7a7f440 03)
A line chart showing the average change of Log10 CFUs (colony-forming units) over a 24-week period. The horizontal axis is labeled Week, and the vertical axis shows the average change of Log10 CFUs. Four lines represent Study 1 and Study 2 results comparing Tobramycin Inhalation Solution and placebo treatments, with drug administration periods indicated at weeks 0-4, 8-12, and 16-20.*
FDA Label Image

Instructions For Use Figure A (98c53b08 1ee0 42d8 89a7 1443b7a7f440 04)

Instructions For Use Figure A (98c53b08 1ee0 42d8 89a7 1443b7a7f440 04)
An instructional diagram illustrating components for administering Tobramycin Inhalation Solution USP 300 mg/5 mL. Labeled parts include an air compressor, nebulizer cup, inspiratory valve cap, ampule of solution, mouthpiece, tubing, and clean paper or cloth towels spread underneath the setup.*
FDA Label Image

Instructions For Use Figure B (98c53b08 1ee0 42d8 89a7 1443b7a7f440 05)

Instructions For Use Figure B (98c53b08 1ee0 42d8 89a7 1443b7a7f440 05)
An instructional illustration showing hands holding single-dose vials of Tobramycin Inhalation Solution USP 300 mg/5 mL, demonstrating a motion to open or prepare the vial for use. The vials are labeled with the product name and strength, indicating the solution form for respiratory inhalation.*
FDA Label Image

Instructions For Use Figure C (98c53b08 1ee0 42d8 89a7 1443b7a7f440 06)

Instructions For Use Figure C (98c53b08 1ee0 42d8 89a7 1443b7a7f440 06)
TOBRAMYCIN Tobramycin Inhalation Solution, USP 300 mg/5 mL in a single-dose vial for respiratory inhalation. The vial label displays the drug name, dosage strength, and space for lot number and expiration date. Labeler is NorthStar RxLLC.*
FDA Label Image

Instructions For Use Figure D (98c53b08 1ee0 42d8 89a7 1443b7a7f440 07)

Instructions For Use Figure D (98c53b08 1ee0 42d8 89a7 1443b7a7f440 07)
An instructional illustration showing the parts and assembly of a nebulizer for respiratory inhalation use. The diagram labels the nebulizer top, nebulizer cup, inspiratory valve cap, tubing, and mouthpiece, with hands demonstrating how to insert the nebulizer top into the nebulizer cup.*
FDA Label Image

Instructions For Use Figure E (98c53b08 1ee0 42d8 89a7 1443b7a7f440 08)

Instructions For Use Figure E (98c53b08 1ee0 42d8 89a7 1443b7a7f440 08)
Illustration showing assembly of a nebulizer device for respiratory inhalation solution. It depicts hands placing the nebulizer insert into the top of the nebulizer cup, with labeled parts for the top, nebulizer insert, and nebulizer cup.*
FDA Label Image

Instructions For Use Figure F (98c53b08 1ee0 42d8 89a7 1443b7a7f440 09)

Instructions For Use Figure F (98c53b08 1ee0 42d8 89a7 1443b7a7f440 09)
An instructional illustration showing components of a nebulizer for respiratory inhalation solution use. It depicts a nebulizer cup and a separate part labeled 'top' placed on a clean paper or cloth towel, indicating proper cleaning or assembly preparation steps.*
FDA Label Image

Instructions For Use Figure G (98c53b08 1ee0 42d8 89a7 1443b7a7f440 10)

Instructions For Use Figure G (98c53b08 1ee0 42d8 89a7 1443b7a7f440 10)
An instructional illustration showing a hand opening or accessing the front compartment of a device labeled 'Pulmo Aide,' likely a medical or respiratory device related to inhalation therapy.*
FDA Label Image

Instructions For Use Figure H (98c53b08 1ee0 42d8 89a7 1443b7a7f440 11)

Instructions For Use Figure H (98c53b08 1ee0 42d8 89a7 1443b7a7f440 11)
An instructional illustration showing a hand plugging a three-prong electrical plug into a standard two-socket outlet. An arrow indicates the motion of inserting the plug into the top socket.*
FDA Label Image

Instructions For Use Figure I (98c53b08 1ee0 42d8 89a7 1443b7a7f440 12)

Instructions For Use Figure I (98c53b08 1ee0 42d8 89a7 1443b7a7f440 12)
Instructional illustration showing a person handling a unit dose vial of Tobramycin inhalation solution, USP 300 mg/5 mL. The image highlights the action of pulling the bottom tab to open the vial for respiratory inhalation use.*
FDA Label Image

Instructions For Use Figure J (98c53b08 1ee0 42d8 89a7 1443b7a7f440 13)

Instructions For Use Figure J (98c53b08 1ee0 42d8 89a7 1443b7a7f440 13)
An instructional illustration showing a hand holding a unit-dose vial labeled with a lot number, dispensing a drop of Tobramycin inhalation solution into a handheld nebulizer device.*
FDA Label Image

Instructions For Use Figure K (98c53b08 1ee0 42d8 89a7 1443b7a7f440 14)

Instructions For Use Figure K (98c53b08 1ee0 42d8 89a7 1443b7a7f440 14)
An instructional diagram showing the assembly of a nebulizer for Tobramycin respiratory inhalation solution. It depicts the nebulizer cup with outlet and handle, and the nebulizer top with stem and semi-circle labeled, illustrating the insertion and rotation needed to secure the top onto the cup.*
FDA Label Image

Instructions For Use Figure L (98c53b08 1ee0 42d8 89a7 1443b7a7f440 15)

Instructions For Use Figure L (98c53b08 1ee0 42d8 89a7 1443b7a7f440 15)
Illustration showing assembly of a nebulizer mouthpiece attaching to the nebulizer outlet on a nebulizer cup. The diagram is labeled with arrows indicating the mouthpiece and nebulizer outlet to guide proper connection for inhalation use.*
FDA Label Image

Instructions For Use Figure M (98c53b08 1ee0 42d8 89a7 1443b7a7f440 16)

Instructions For Use Figure M (98c53b08 1ee0 42d8 89a7 1443b7a7f440 16)
An instructional illustration showing the inspiratory valve cap being aligned and placed onto a respiratory inhalation device, demonstrating components of the assembly.*
FDA Label Image

Instructions For Use Figure N (98c53b08 1ee0 42d8 89a7 1443b7a7f440 17)

Instructions For Use Figure N (98c53b08 1ee0 42d8 89a7 1443b7a7f440 17)
An instructional diagram showing the assembly of a respiratory inhalation device's air intake component. It illustrates the connection point between the main inhalation chamber and the tubing, with arrows indicating how to attach the tubing to the air intake.*
FDA Label Image

Instructions For Use Figure O (98c53b08 1ee0 42d8 89a7 1443b7a7f440 18)

Instructions For Use Figure O (98c53b08 1ee0 42d8 89a7 1443b7a7f440 18)
Illustration showing a hand pressing a button or switch on a device labeled 'Pulmo Aide.' The image likely depicts an instructional step for operating the Pulmo Aide, a nebulizer device commonly used for respiratory inhalation treatments.*
FDA Label Image

Instructions For Use Figure P (98c53b08 1ee0 42d8 89a7 1443b7a7f440 19)

Instructions For Use Figure P (98c53b08 1ee0 42d8 89a7 1443b7a7f440 19)
An instructional illustration showing a nebulizer mouthpiece emitting mist, representing use of an inhalation solution device.*
FDA Label Image

Instructions For Use Figure Q (98c53b08 1ee0 42d8 89a7 1443b7a7f440 20)

Instructions For Use Figure Q (98c53b08 1ee0 42d8 89a7 1443b7a7f440 20)
An instructional illustration showing a person using a respiratory inhalation device with a nose clip applied. The device is positioned at the mouth for inhalation, and the label identifies the nose clip to be worn on the nose during use.*
FDA Label Image

Pouch Label (98c53b08 1ee0 42d8 89a7 1443b7a7f440 21)

Pouch Label (98c53b08 1ee0 42d8 89a7 1443b7a7f440 21)
TOBRAMYCIN Inhalation Solution USP 300 mg/5 mL label for respiratory use by nebulizer. The sterile solution contains no preservatives and is supplied in a pouch with four single-dose 5 mL ampules. Labeler is NorthStar Rx LLC. Storage instructions specify refrigeration. The label also notes it's for prescription use only.*
FDA Label Image

Carton (98c53b08 1ee0 42d8 89a7 1443b7a7f440 22)

Carton (98c53b08 1ee0 42d8 89a7 1443b7a7f440 22)
Box label for Tobramycin Inhalation Solution, USP 300 mg/5 mL by NorthStar Rx LLC. The label states the product is for inhalation only by nebulizer, sterile, contains no preservatives, and requires refrigeration. The carton contains 56 single-dose 5 mL ampules, grouped as 14 pouches of 4 ampules each, representing a 28-day supply. Manufactured by Mankind Pharma Limited, India, and product of Hungary.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.